Clinical Trial Update: Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating RSD1235 versus placebo for atrial fibrillation or atrial flutter after heart surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• RSD1235

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 3 | Status: COMPLETED